Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2008
10/23/2008WO2008053341A3 Bridged bicyclic indazoles as cannabinoid receptor ligands
10/23/2008WO2008040995A8 Indazoles for use as dpp-iv inhibitors
10/23/2008WO2006118488A3 Processed sunflower black seed oil and use thereof in pharamac eut i cal and cosmetic compositions
10/23/2008US20080263689 Screening/monitoring rate of internalization of insulin receptors in insulin-stimulated hepatocytes; identifying modulators of insulin clearance and secretion; treating insulin resistance
10/23/2008US20080262411 treatment of obesity by electrical activation or deactivation of the nervous system, using electrodes, then further performing surgery and administering anorexigenic agents
10/23/2008US20080262205 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
10/23/2008US20080262096 Squaric Acid Derivatives
10/23/2008US20080262093 Contacting a cell expressing PGC-1 with various amount of respiration uncoupling agent to determing the resulting maximum PGC-1 level and therefore the upper limit of the safe dosage for the agent; decreasing fat mass/adipocity or increasing weight loss; antidiabetic agents; eating/metabolic disorders
10/23/2008US20080262088 Methods, compounds, and compositions for treating metabolic disorders and diabetes
10/23/2008US20080262066 azole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders.
10/23/2008US20080262063 Novel inhibitors of glutaminyl cyclase
10/23/2008US20080262062 disease treatable with PARP modulators by identifying a level of PARP in a plurality of samples from a population, making a decision regarding identifying the disease treatable by the PARP modulators wherein the decision is made based on the level of PARP
10/23/2008US20080262059 AT 1-antagonist vaisertan or a pharmaceutically acceptable salt thereof; and(ii) a NEP inhibitor or a pharmaceutically acceptable salt thereof and optionally a pharmaceutically acceptable carrier and to a method for the treatment or prevention of a condition or diseaseselected from hypertension
10/23/2008US20080262054 Pharmaceutical Composition Containing Thiazolidinedione Compound
10/23/2008US20080262052 disorders of lipid and/or carbohydrate metabolism, metabolic disorders, central nervous system disorders; 3-{2-Chloro-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazole-5-one
10/23/2008US20080262050 Organic Compounds
10/23/2008US20080262046 Amidopropoxyphenyl Orexin Receptor Antagonists
10/23/2008US20080262040 novel indazole carboxamide derivatives for inflammatory and tissue repair disorders like rheumatoid arthritis, asthma, and COPD; kinase inhibitors in particular IKK2; 1,1-dimethylethyl-4-[4-(aminocarbonyl)-6-phenyl-1H-indazol-1-yl]-1-piperidinecarboxylate; intermediates
10/23/2008US20080262036 Phenyl-[1,2,4]-oxadiazol-5-one Derivatives, Pharmaceutical Compositions and Therapeutic Use Thereof
10/23/2008US20080262032 Isoxazoline Derivative and Novel Process for Its Preparation
10/23/2008US20080262028 Imidazole derivatives as inhibitors of tafia
10/23/2008US20080262016 Isoquinoline derivatives and methods of use thereof
10/23/2008US20080262002 Use of S-Adenosylmethionine, Vitamin E, and Vitamin C for the Treatment of Oxidative Liver Injury or Insulin Resistance
10/23/2008US20080261981 3-{4-[4-(2-amino-3-morpholin-4-yl-3-oxo-propyl)-phenoxy]-phenyl}-N-hydroxypropionamide hydrochloride; for reducing blood glucose, free fatty acids, cholesterol, triglycerides levels
10/23/2008US20080261979 Phenyl-1,2,4-Oxadiazolone Derivatives, Processes For Their Preparation and Methods For Their Use as Pharmaceuticals
10/23/2008US20080261976 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
10/23/2008US20080261970 metabolic syndrome; diabetes; obesity; N-(2-(benzyloxy)-1-(6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-1-methylpiperidine-4-sulfonamide
10/23/2008US20080261949 ethyl 4-[4-(2-hydroxy-3-(4-hydroxy-3-(methylsulphonylamino)phenoxy)propylamino)cyclohexyl]benzoic acid; beta-3 adrenergic receptor agonist; tocolytics; delaying preterm birth; antidiabetic; obesity; oxyalkylation of the phenyl(alkyl)cyclohexyl(alkyl)amine with a glycidyl ether
10/23/2008US20080261948 Ligands for G-Protein Coupled Receptors
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261943 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
10/23/2008US20080261942 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
10/23/2008US20080261936 Treatment of obesity and/or overweight; comprising, for example, a therapeutically effective amount of oleoyl-estrone in canola oil, wherein the composition is suitable for oral administration
10/23/2008US20080261927 Nutrient phytosterol or phytostanol ester with dispersion aid selected from triglyceride, an essential oil extract, night primrose oil, and/or fish oil; beverages, cosmetics
10/23/2008US20080261913 Compounds and pharmaceutical compositions for the treatment of liver disorders
10/23/2008US20080261896 Testosterone generating and metabolizing enhancer
10/23/2008US20080261885 Conglycinin fragments extracted from ground, defatted soy, then precipitated by treatment with aqueous ethanol; metal affinity chromatography; treating with chymotrypsin; hyperlipidemia
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080261872 Use of Ghrelin and Unacylated Ghrelin Compositions in Insulin-Related Disease Conditions
10/23/2008US20080261871 Y2/Y4 Selective Receptor Agonists for Therapeutic Interventions
10/23/2008US20080261868 Administering serine protease inhibitor such as antitrypsin; antiapoptosis; cancer, autoimmune disease, sepsis neurodegenerative disease, myocardial infarction, stroke, ischemia-reperfusion injury, toxin induced liver injury and AIDS
10/23/2008US20080261864 Insulin signalling pathway modulators, compounds influencing a dysregulated hepatic glucose production, pyruvate dehydrogenase kinase (PDHK) inhibitors, inhibitors of gastric emptying, insulin, inhibitors of GSK-3, retinoid X receptor (RXR) agonists, agonists of uncoupling protein
10/23/2008US20080261863 Pegylation of Vasoactive Intestinal Peptide (Vip) / Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 2 (Vpac2) Agonists and Methods of Use
10/23/2008US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor
10/23/2008US20080260881 Blue-green algae composition
10/23/2008US20080260843 transpulmonary composition
10/23/2008US20080260840 glucagon-like peptide-1; osmotic drug delivery device and method
10/23/2008US20080260838 Pulmonary delivery of GLP in combination with diketopiperazine that is stable both in vitro and in vivo; diabetes, cancers, and obesity
10/23/2008US20080260820 Providing effective gastrointestinal tract drug delivery; therapeutic protein having primary amino acid sequence modification
10/23/2008US20080260781 Proteosome influenza vaccine
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260736 Using transforming growth factor modulators to regulate hepcidin expression and treat hemochromatosis
10/23/2008US20080260727 Modulation of Nkg2d
10/23/2008US20080260709 Probiotic yeast broth for reducing blood or hepatic cholesterol level and preventing and/or treating cell proliferative and atherogenic disorders
10/23/2008US20080260700 Immortalized pancreatic duct cell for use in treatment of pancreatic disorders and insulin sensitivity; tissue engineering and repair; regenerative medicine
10/23/2008US20080260688 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
10/23/2008CA2683915A1 Pyrimidinedione derivatives and methods of use thereof
10/23/2008CA2683695A1 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives
10/23/2008CA2683586A1 Substituted furo[2,3-beta]pyridine derivatives as cannabinoid 1-receptor modulators
10/23/2008CA2683089A1 Benzimidazole derivatives and imidazopyridine derivatives with glucose lowering effect
10/23/2008CA2682598A1 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
10/23/2008CA2681444A1 Ranolazine for enhancing insulin secretion
10/23/2008CA2681311A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/23/2008CA2680751A1 Anti-fatigue agent
10/23/2008CA2668305A1 Azaindole derivatives as cftr modulators
10/23/2008CA2660201A1 Organic compounds
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1982724A1 Therapeutic agent for metabolic syndrome and food containing the therapeutic agent
10/22/2008EP1982713A2 Substituted benzoxazoles and analogues as estrogenic agents
10/22/2008EP1981882A1 Amide substituted quinolines
10/22/2008EP1981873A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof
10/22/2008EP1981849A1 Heterocyclic compounds
10/22/2008EP1981595A1 Method to control body weight
10/22/2008EP1981518A1 Peganine isolated from anisotes trisulcus l. as a smoking deterrent and anorxigenic agent
10/22/2008EP1981516A2 Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders
10/22/2008EP1981495A2 Use of vildagliptin for the treatment of diabetes
10/22/2008EP1981494A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor
10/22/2008EP1981490A1 Long term weight maintenance
10/22/2008EP1472257B1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
10/22/2008EP1425265B1 Derivatives of c2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments
10/22/2008EP1425018B1 Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008EP1404349B1 Fat-binding polymers
10/22/2008EP1318983B1 Substituted imidazoles as histamine h1 and h3 agonists or antagonists
10/22/2008CN101292020A A process for the removal of sterols and other compounds from glycerol oils
10/22/2008CN101291932A Triazolopyridine derivatives as inhibitors of lipases and phospholipases
10/22/2008CN101291918A Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
10/22/2008CN101291912A Pyrazole derivatives, compositions containing such compounds and methods of use
10/22/2008CN101291685A Exendin for treating diabetes and reducing body weight
10/22/2008CN101291682A Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts
10/22/2008CN101289477A N-phenylpropenoyl chitosan oligosaccharide and preparation thereof
10/22/2008CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents
10/22/2008CN101289418A Miglitol crystal and method for preparing same
10/22/2008CN101288742A Medicinal composition for preventing birth defect and improving memory
10/22/2008CN101288741A Medicinal composition for preventing birth defect and improving memory and intelligence
10/22/2008CN101288737A Chinese medicine for reducing blood fat and its preparation method
10/22/2008CN101288731A Medicine composition for preventing birth defect and improving memory
10/22/2008CN101288730A Medicine composition for preventing birth defect and improving memory
10/22/2008CN101288726A Medicine composition for adjusting blood fat and its preparation method
10/22/2008CN101288717A Medicine composition for preventing birth defect and improving memory
1 ... 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 ... 1298